CutisPharma, Inc., brings innovation and value to the prescription-compounding sector of hospital and health-system pharmacies. Unit-of-Use kits simplify the entire process—they quicken preparation, enhance patient safety, and facilitate reimbursements. What typically takes compounders up to fifteen minutes to do now takes just one minute or less. All kits are bar-coded and facilitate pharmacists’ conformance to USP Chapter <795> standards.
Greater efficiencies in the compounding process bring multiple financial and clinical gains to hospital and health-system pharmacies. By using pre-measured, pre-weighed unit-of-use prescription compounding kits, pharmacies and nurses save significant staff time in preparation, help lower the total costs of compounding, facilitate reimbursements, and refine their just-in-time inventories to ensure ingredients are on hand when needed and ready to use over longer periods of shelf life.
At A Glance
Clinically, the packaged reagents help deliver consistent accuracy of the compound admixtures and quicken medication delivery to patients, if compounded according to instructions, because they’re easier and quicker to use than the typical laborious processes. These benefits in turn may lead to better patient health outcomes.
Industry-wide savings can be vast. FDA estimates 30 million hospital-outpatient and retail compounding prescriptions are filled per year. Inpatient figures are also significant, yet harder to pinpoint because they lack a single NDC number, says Jim Nagle, Vice President-Business Development, CutisPharma, Woburn, MA. Every FI℞ST® – Unit-of-Use kit end-use container has a bar code.
The NDC number imprinted on each end-use container in every CutisPharma FI℞ST® Unit-of-Use kit facilitates third-party reimbursement for hospitals and health systems. The single NDC number for the entire kit may also improve patient safety, because of minimized dispensing errors, suiting the growing number of inpatient and outpatient pharmacies that barcode prescriptions from point of dispensing to point of care.
Now available: FI℞ST® – Omeprazole and FI℞ST® – Lansoprazole Suspension Unit-of-Use Compounding Kits in 3, 5 and 10 oz sizes.
CutisPharma, Inc., introduced in January 2012, FI℞ST® - Omeprazole and FI℞ST® - Lansoprazole Unit-of-Use oral suspension compounding kits. These new kits will help pharmacists dispense these compounded prescriptions containing widely used proton pump inhibitors (PPIs). Traditionally, compounded omeprazole and lansoprazole oral suspensions can take up to several hours to prepare and are quite unpleasant to the taste. With FI℞ST® – Omeprazole and FI℞ST® - Lansoprazole, pharmacists need only add the liquid suspension to the powder, shake, and then within minutes can dispense to the patient with improved flavoring.
“We invested a lot of time to develop these new suspension kits. The results are a pleasant-tasting strawberry-flavored medication with adequate stability once compounded,” said Dr. Indu Muni, founder, chairman, and CEO of CutisPharma, Inc. “These products offer another advantage for hospital use; since the suspensions are made using powders, and not pellets, our new compounded suspensions should flow more easily through nasogastric (NG) tubes, with minimal clogging compared to current practice. Also, our three different sizes of packaging, 3 oz, 5 oz and 10 oz, provide considerable prescribing flexibility.”
The FI℞ST® Magic Mouthwash line contains FI℞ST® _ Mouthwash BLM 4, 6 and 8 oz sizes, BXN, Duke’s and Mary’s versions.
CutisPharma, Inc., announced the introduction of FI℞ST® – Mouthwash BLM 4 oz and FI℞ST® - Mouthwash BLM 6 oz compounding kits. These products expand the FI℞ST® Magic Mouthwash line for CutisPharma. The product line already includes FI℞ST® – Mouthwash BLM 8 oz, Duke’s Mouthwash, Mary’s Mouthwash and BXN Mouthwash. The active ingredients in FI℞ST® – Mouthwash BLM are comparable to those found in the most routinely prepared formulation of Magic Mouthwash containing Benadryl®, lidocaine and Maalox®. The kits are made for one patient and include pre-weighed powders and a pre-measured suspension. With FI℞ST® – Mouthwash Kits, the pharmacist needs only to add the powders to the liquid suspension, shake, and then dispense to the patient.
“Pharmacies have told CutisPharma, and our research has indicated that there are just as many 4 oz and 6 oz prescriptions for ‘Magic Mouthwash’ containing Benadryl®, lidocaine and Maalox® as there are for 8 oz prescriptions. By launching FI℞ST® – Mouthwash BLM 4 oz and 6 oz, pharmacists now have greater flexibility in filling FI℞ST® ‘Magic Mouthwash’ prescriptions,” said Dr. Muni. “The Company now has a wide range of FI℞ST® ‘Magic Mouthwash’ formulations to choose from, particularly for the most commonly prescribed and used.”
FI℞ST® products save dispensing time, and can be compounded by the pharmacist while the patient waits, increasing customer satisfaction. Using FI℞ST® Mouthwash kits, the pharmacist can compound a prescription faster than those prepared in the conventional way.
Primarily prescribed for physical therapy patients, the FI℞ST® 10% Hydrocortisone in Ultrasound Gel Compounding Kit made for a single patient, contains 6 grams of micronized hydrocortisone USP in a 24-gram suspension with propylene glycol USP and simethicone USP. It also includes 36 grams of ultrasound gel for topical use. The kit has a two-year shelf life prior to compounding.
There are approximately 350,000 10% Hydrocortisone in Ultrasound Gel prescriptions written annually. CutisPharma cost comparison shows that FI℞ST® 10% Hydrocortisone unit-of-use kit can yield a profit of over $9 for a compounding pharmacy vs. a loss of over $16 when the admixture is compounded conventionally. Also, preparation time is cut to two minutes from well over fifteen minutes.
The CutisPharma portfolio is growing to meet pharmacy’s increasing reliance on compounding—and its need for efficiencies, safety and convenience.
CutisPharma now has twenty proprietary prescription compounding kits on the market: five progesterone suppository compounding kits, two testosterone kits, one hydrocortisone kit, six Magic Mouthwash kits, three omeprazole suspension kits and three lansoprazole suspension kits. Several more compounding kits are in the planning stages. The use of FI℞ST® Unit-of-Use Prescription Compounding Kits facilitates compliance with United States Pharmacopeia (USP) Chapter <795>.
This corporate profile was reviewed and approved by CutisPharma, Inc.